June 2022
1. ARMENIAN SH, Chen Y, Hageman L, Wu J, et al
   Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
   J Clin Oncol. 2022 Jun 22:JCO2102829. doi: 10.1200/JCO.21.02829.
   

   >> Share

   
   
2. BHATIA S, Dai C, Landier W, Hageman L, et al
   Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report.
   J Clin Oncol. 2022;40:1991-2003.
   

   >> Share

   
   April 2022
3. SOIFFER RJ
   Naive T-Cell Depletion to Prevent GVHD: Searching for a Better Mousetrap.
   J Clin Oncol. 2022;40:1139-1141.
   

   >> Share

   
   April 2021
4. SHAW BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, et al
   National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide.
   J Clin Oncol. 2021 Apr 27:JCO2003502. doi: 10.1200/JCO.20.03502.
   

   >> Share

   
   July 2020
5. MCDONALD AM, Chen Y, Wu J, Hageman L, et al
   Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.
   J Clin Oncol. 2020 Jul 16:JCO2000231. doi: 10.1200/JCO.20.00231.
   

   >> Share

   
   April 2020
6. SHARAFELDIN N, Richman J, Bosworth A, Chen Y, et al
   Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic Malignancy.
   J Clin Oncol. 2020;38:1312-1321.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share